GT
DARE icon

Glenmede Trust’s Dare Bioscience DARE Stock Holding History

Glenmede Trust’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-9
Closed -$4K – 2739
2015
Q2 		$4K Buy
+9
New +$6.18K ﹤0.01% 2276

Other funds holding DARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Glenmede Trust's DARE Position: Q3 2015 in Review

Glenmede Trust sold out of Dare Bioscience (DARE) in Q3 2015, closing a stake of 9 shares — an estimated $4K sold.

Glenmede Trust first reported a position in DARE in Q2 2015 and held it in 1 quarter. The position peaked at $4K in Q2 2015. 38 funds tracked by Wall St. Rank hold DARE as of Q3 2015.

  • Glenmede Trust reported no remaining Dare Bioscience position as of Q3 2015 after selling out during the quarter.
  • Glenmede Trust sold 9 Dare Bioscience shares in Q3 2015, an estimated $4K.
  • Glenmede Trust first reported a position in Dare Bioscience in Q2 2015 and held it in 1 quarter.
  • Glenmede Trust's Dare Bioscience position peaked at $4K in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2015.

Based on Glenmede Trust's 13F filing for Q3 2015, filed 12 Nov 2015.